Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Exploring innovative regulatory pathways: a US perspective

  • In: Symposium D1: New approaches of regulating innovative medicines on Monday, 22 May 2017, 15:45-16:20
  • At: Stockholm (Sweden) (2017)
  • Type: Presentation
  • By: LIBERTI, Lawrence (CIRS, Holland, United States)
  • Co-author(s): Lawrence Liberti: CIRS, Holland, United States
  • Abstract:

    Pharmaceutical innovation results from the efficient partnership between drug developers, regulators, payers and patients among others stakeholders.   A regulatory agency, with the support of its legislature, can stimulate and support innovation through the active application of various elements of regulatory science. In the US, programmes have

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses